2022 年美国代谢与减重外科学会（ASMBS）和国际肥胖与代谢外科联合会（IFSO）代谢与减重手术适应证。
2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery.
机构信息
Department of Surgery, Stanford School of Medicine, VA Palo Alto Health Care System, 3801 Miranda Avenue, GS 112, Palo Alto, CA, 94304, USA.
Department of Surgery, Center for Metabolic and Bariatric Surgery, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
出版信息
Obes Surg. 2023 Jan;33(1):3-14. doi: 10.1007/s11695-022-06332-1.
Abstract
MAJOR UPDATES TO 1991 NATIONAL INSTITUTES OF HEALTH GUIDELINES FOR BARIATRIC SURGERY: Metabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) >35 kg/m, regardless of presence, absence, or severity of co-morbidities.MBS should be considered for individuals with metabolic disease and BMI of 30-34.9 kg/m.BMI thresholds should be adjusted in the Asian population such that a BMI >25 kg/m suggests clinical obesity, and individuals with BMI >27.5 kg/m should be offered MBS.Long-term results of MBS consistently demonstrate safety and efficacy.Appropriately selected children and adolescents should be considered for MBS.(Surg Obes Relat Dis 2022; https://doi.org/10.1016/j.soard.2022.08.013 ) © 2022 American Society for Metabolic and Bariatric Surgery. All rights reserved.
摘要
1991 年美国国立卫生研究院减重手术指南的重大更新：代谢和减重手术（MBS）推荐用于体重指数（BMI）>35 kg/m²的个体，无论是否存在合并症及其严重程度如何。对于代谢疾病且 BMI 为 30-34.9 kg/m²的个体，应考虑进行 MBS。应调整亚洲人群的 BMI 阈值，使 BMI>25 kg/m²提示临床肥胖，而 BMI>27.5 kg/m²的个体应提供 MBS。MBS 的长期结果始终显示出安全性和有效性。应考虑对适当选择的儿童和青少年进行 MBS。（Surg Obes Relat Dis 2022; https://doi.org/10.1016/j.soard.2022.08.013 ）©2022 年美国代谢与减重外科学会。保留所有权利。
相似文献
1
2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery.
Obes Surg. 2023 Jan;33(1):3-14. doi: 10.1007/s11695-022-06332-1.
2
[Interpretation for indications of metabolic and bariatric surgery released by ASMBS and IFSO in 2022].
Zhonghua Wei Chang Wai Ke Za Zhi. 2023 Apr 25;26(4):385-388. doi: 10.3760/cma.j.cn441530-20221221-00534.
3
2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery.
Surg Obes Relat Dis. 2022 Dec;18(12):1345-1356. doi: 10.1016/j.soard.2022.08.013. Epub 2022 Oct 21.
4
Indications and Coverage of Metabolic and Bariatric Surgery: A Worldwide IFSO Survey Comparing Different National Guidelines.
Obes Surg. 2024 May;34(5):1395-1404. doi: 10.1007/s11695-024-07142-3. Epub 2024 Mar 13.
5
Scientific evidence for the updated guidelines on indications for metabolic and bariatric surgery (IFSO/ASMBS).
Surg Obes Relat Dis. 2024 Nov;20(11):991-1025. doi: 10.1016/j.soard.2024.05.009. Epub 2024 Jun 11.
6
Metabolic Bariatric Surgery Across the IFSO Chapters: Key Insights on the Baseline Patient Demographics, Procedure Types, and Mortality from the Eighth IFSO Global Registry Report.
Obes Surg. 2024 May;34(5):1764-1777. doi: 10.1007/s11695-024-07196-3. Epub 2024 Apr 9.
7
Current recommendations for procedure selection in class I and II obesity developed by an expert modified Delphi consensus.
Sci Rep. 2024 Feb 11;14(1):3445. doi: 10.1038/s41598-024-54141-6.
8
Methodology and Results of a Joint IFSO-WGO Delphi Survey of 94 Intercontinental, Interdisciplinary Experts in Obesity Management.
Obes Surg. 2023 Nov;33(11):3337-3352. doi: 10.1007/s11695-023-06757-2. Epub 2023 Oct 13.
9
Updates in Bariatric Surgery.
Am Surg. 2024 May;90(5):925-933. doi: 10.1177/00031348231220576. Epub 2023 Dec 7.
10
ASMBS pediatric metabolic and bariatric surgery guidelines, 2018.
Surg Obes Relat Dis. 2018 Jul;14(7):882-901. doi: 10.1016/j.soard.2018.03.019. Epub 2018 Mar 23.
引用本文的文献
1
Bariatric Surgery and Incident Development of Obesity-Related Comorbidities.
JAMA Netw Open. 2025 Sep 2;8(9):e2530787. doi: 10.1001/jamanetworkopen.2025.30787.
2
Cost-Effectiveness of Obesity Treatments: Glucagon-Like Peptide-1 Receptor Agonists, Endoscopic Sleeve Gastroplasty, and Metabolic/Bariatric Surgery.
J Metab Bariatr Surg. 2025 Aug;14(2):97-105. doi: 10.17476/jmbs.2025.14.2.97. Epub 2025 Aug 18.
3
Pregnancy Outcomes Following Different Types of Bariatric Surgery: A Network Meta-Analysis.
Obes Surg. 2025 Sep 3. doi: 10.1007/s11695-025-08009-x.
4
Clarifying the 2022 IFSO/ASMBS Metabolic and Bariatric Surgery Guidelines for Asians: Safeguarding Against Misapplication.
Obes Surg. 2025 Sep 1. doi: 10.1007/s11695-025-08237-1.
5
Assessing the Safety and Aesthetic Benefits of Reduced Port Bikini-Line Sleeve Gastrectomy (RBSG): An Initial Report.
Obes Surg. 2025 Aug 20. doi: 10.1007/s11695-025-08176-x.
6
Heart failure with preserved ejection fraction and obesity: emerging metabolic therapeutic strategies.
Diabetol Metab Syndr. 2025 Aug 18;17(1):336. doi: 10.1186/s13098-025-01917-z.
7
The Effect of Ultrasound-Guided Multipoint Thoracic Paravertebral Nerve Block in Metabolic and Bariatric Surgery (MBS): A Prospective Randomized Controlled Trial.
Obes Surg. 2025 Aug 18. doi: 10.1007/s11695-025-08154-3.
8
Metabolic surgery versus usual care effects on mortality among patients with obesity and type 2 diabetes: A systematic review and meta-analysis.
J Res Med Sci. 2025 Jul 24;30:41. doi: 10.4103/jrms.jrms_360_24. eCollection 2025.
9
"Just put in a little more effort": the help-seeking experience of patients living with obesity.
Int J Obes (Lond). 2025 Aug 14. doi: 10.1038/s41366-025-01867-6.
10
Physiotherapy in Prehabilitation for Bariatric Surgery-Analysis of Its Impact on Functional Capacity and Original Predictive Models of Functional Status Outcome.
J Clin Med. 2025 Jul 25;14(15):5265. doi: 10.3390/jcm14155265.
本文引用的文献
1
Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial.
JAMA Surg. 2022 Aug 1;157(8):656-666. doi: 10.1001/jamasurg.2022.2229.
2
Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity.
JAMA. 2022 Jun 28;327(24):2423-2433. doi: 10.1001/jama.2022.9009.
3
Outcomes of bariatric surgery in patients with left ventricular assist device.
J Heart Lung Transplant. 2022 Jul;41(7):914-918. doi: 10.1016/j.healun.2022.04.003. Epub 2022 Apr 10.
4
Long-Term Cardiovascular Outcomes After Bariatric Surgery in the Medicare Population.
J Am Coll Cardiol. 2022 Apr 19;79(15):1429-1437. doi: 10.1016/j.jacc.2022.01.047.
5
Effect of Bariatric Surgery on Risk of Complications After Total Knee Arthroplasty: A Randomized Clinical Trial.
JAMA Netw Open. 2022 Apr 1;5(4):e226722. doi: 10.1001/jamanetworkopen.2022.6722.
6
Effect of bariatric surgery versus medical therapy on long-term cardiovascular risk in low BMI Chinese patients with type 2 diabetes: a propensity score-matched analysis.
Surg Obes Relat Dis. 2022 Apr;18(4):475-483. doi: 10.1016/j.soard.2021.11.019. Epub 2021 Nov 22.
7
Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
JAMA. 2021 Nov 23;326(20):2031-2042. doi: 10.1001/jama.2021.19569.
8
Treating the Chronic Disease of Obesity.
Med Clin North Am. 2021 Nov;105(6):983-1016. doi: 10.1016/j.mcna.2021.06.005.
9
ASMBS position statement on preoperative patient optimization before metabolic and bariatric surgery.
Surg Obes Relat Dis. 2021 Dec;17(12):1956-1976. doi: 10.1016/j.soard.2021.08.024. Epub 2021 Sep 3.
10
Ten-Year Outcomes of Children and Adolescents Who Underwent Sleeve Gastrectomy: Weight Loss, Comorbidity Resolution, Adverse Events, and Growth Velocity.
J Am Coll Surg. 2021 Dec;233(6):657-664. doi: 10.1016/j.jamcollsurg.2021.08.678. Epub 2021 Sep 23.
Zotero 插件